Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Spero Therapeutics (SPRO) over the last 10 years, with Q3 2025 value amounting to $1.2 million.

  • Spero Therapeutics' Prepaid Assets fell 3927.01% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 3927.01%. This contributed to the annual value of $1.9 million for FY2024, which is 5426.04% down from last year.
  • Per Spero Therapeutics' latest filing, its Prepaid Assets stood at $1.2 million for Q3 2025, which was down 3927.01% from $1.3 million recorded in Q2 2025.
  • Spero Therapeutics' Prepaid Assets' 5-year high stood at $8.8 million during Q4 2021, with a 5-year trough of $1.2 million in Q3 2025.
  • Moreover, its 5-year median value for Prepaid Assets was $3.7 million (2024), whereas its average is $4.2 million.
  • As far as peak fluctuations go, Spero Therapeutics' Prepaid Assets crashed by 7420.25% in 2022, and later surged by 26344.09% in 2023.
  • Spero Therapeutics' Prepaid Assets (Quarter) stood at $8.8 million in 2021, then plummeted by 61.73% to $3.4 million in 2022, then grew by 23.65% to $4.2 million in 2023, then crashed by 54.26% to $1.9 million in 2024, then tumbled by 34.69% to $1.2 million in 2025.
  • Its Prepaid Assets stands at $1.2 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.5 million for Q1 2025.